Recommendations for the Equitable and Widespread Implementation of Liquid Biopsy for Cancer Care
The Blood Profiling Atlas in Cancer Consortium (BLOODPAC) has published a new paper, “Recommendations for the Equitable and Widespread Implementation of Liquid Biopsy for Cancer Care,” in the January issue of JCO Precision Oncology. The article centers on a key challenge for liquid biopsy – accessibility. Liquid biopsy tests have the potential to reduce health inequities in cancer care by making screening, therapy selection, and post-treatment monitoring less burdensome and invasive for patients and health professionals. The authors of the article, members of BLOODPAC’s accessibility working group, provide an overview of barriers to adoption and recommend specific actions to ensure equitable access to all patients.
